NASDAQ·Biological Products, (No Diagnostic Substances)
DYAI
DYADIC INTERNATIONAL INC
DYADIC INTERNATIONAL INC (ticker: DYAI) is an NASDAQ-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of DYAI's SEC filings surfaces 5 active risk signals, including 3 late-filing signals, 1 auditor-change signal, and 1 delisting/deregistration signal. DYAI reported $1.11M in revenue and -$1.95M for the period ending 2026-03-31, with operating cash flow of -$1.96M. Cash and equivalents stood at $4.25M (down 16.1% year-over-year). Total assets of $7.81M are exceeded by total liabilities of $8.22M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
DYAI SEC Filings
Full cached SEC EDGAR filing history for DYAI, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.